Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIQUISPEX URINE (MICRO)ALBUMIN CONTROL

K-Number: K962432 · 1996-07-05

ApplicantClinical Controls, Inc.
Decision Date1996-07-05
Product CodeJJX
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

LIQUISPEX URINE (MICRO)ALBUMIN CONTROL is the device name listed in this FDA 510(k) record. The listed applicant is Clinical Controls, Inc.. It received FDA 510(k) clearance on 1996-07-05 under 510(k) number K962432. The device is classified under product code JJX. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIQUISPEX URINE (MICRO)ALBUMIN CONTROL?

LIQUISPEX URINE (MICRO)ALBUMIN CONTROL is a medical device that received FDA 510(k) clearance on 1996-07-05. The listed applicant is Clinical Controls, Inc.. The 510(k) number is K962432.

When did LIQUISPEX URINE (MICRO)ALBUMIN CONTROL receive FDA 510(k) clearance?

LIQUISPEX URINE (MICRO)ALBUMIN CONTROL received FDA 510(k) clearance on 1996-07-05, under 510(k) number K962432.

Who is the listed applicant for LIQUISPEX URINE (MICRO)ALBUMIN CONTROL?

The FDA 510(k) record lists Clinical Controls, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LIQUISPEX URINE (MICRO)ALBUMIN CONTROL?

The FDA product code for LIQUISPEX URINE (MICRO)ALBUMIN CONTROL is JJX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Clinical Controls, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K964278WHOLE BLOOD GLUCOSE CONTROL LEVEL 1,2,AND 3/WHOLE BLOOD GLUCOSE LINEARITY CONTROL-LEVEL1,2,3,4,5,AND 6K955690AQUEOUS ETHANOL/AMMONIA CONTROL LEVEL 1, 2, & 3K955691SERUM VOLATILES CONTROL LEVEL 1 & 2K946265FIBRINOGEN HIGH ABNORMAL CONTROL - LEVEL 3K935598PLASMA FIBRINOGEN CONTROL LEVEL 1/LEVEL 2K946049LIQUISPEX(TM) LIQUID B2M/CRP CONTROL LEVEL 1 AND 2

View all 17 devices →

Related Devices (Code: JJX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K170678Beta-CrossLaps CalCheck 5Roche DiagnosticsK162173Elecsys CYFRA 21-1 CalCheck 5Roche DiagnosticsK162514Multichem A1cTechnopath ManufacturingK161874Audit MicroControls Linearity DROP LQ Blood GlucoseAalto Scientific, Ltd.K161526LIAISON CMV IgM Serum Control SetDiaSorin, Inc.K161522LIAISON EBV IgM Serum Control SetDiaSorin, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑